IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Copernicus Capital Management, LLC

Q3 2021 Holdings

Filed 2021-11-15 | 13 holdings | $1.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$850.0K11,00046.3%
Arcus Biosciences Inc(RCUS)COM03969F109$593.0K17,00032.3%
Allogene Therapeutics Inc(ALLO)COM019770106$386.0K15,00021.0%
Pfizer Inc(PFE)COM717081103$1.3K30,0000.1%
Thermo Fisher Scientific Inc(TMO)COM883556102$1.1K2,0000.1%
Teladoc Health Inc(TDOC)COM87918A105$8887,0000.0%
Johnson & Johnson(JNJ)COM478160104$8085,0000.0%
Fate Therapeutics Inc(FATE)COM31189P102$71112,0000.0%
Horizon Therapeutics PUB LSHSG46188101$6576,0000.0%
Medtronic PLC(MDT)SHSG5960L103$3763,0000.0%
Proqr Thrapeutics N VSHS EURON71542109$33540,0000.0%
Immatics N.v(IMTX)SHSN44445109$13010,0000.0%
Amicus Therapeutics Inc(FOLD)COM03152W109$9610,0000.0%